IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

未开盘 12-20 16:00:00 EST

0.2488

+0.0084

+3.49%

盘后0.2500

+0.0012+0.48%

19:51 EST

最高0.2552	最低0.2303	成交量132.98万
今开0.2310	昨收0.2404	日振幅10.36%
总市值1,803万	流通市值1,350万	总股本7,248万
成交额33.03万	换手率2.45%	流通股本5,425万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":0.2488,"timestamp":1734728400000,"preClose":0.2404,"halted":0,"volume":1329795,"hourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.2488,"latestTime":"19:51 EST","volume":83305,"amount":21278.3585,"timestamp":1734742262626},"delay":0,"floatShares":54251569,"shares":72483253,"eps":-0.742548,"marketStatus":"未开盘","marketStatusCode":0,"change":0.0084,"latestTime":"12-20 16:00:00 EST","open":0.231,"high":0.2552,"low":0.2303,"amount":330266.370234,"amplitude":0.103577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742548,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1605157200000,"adjPreClose":0.2404,"preHourTrading":{"tag":"盘前","latestPrice":0.248,"preClose":0.2404,"latestTime":"09:29 EST","volume":22385,"amount":5451.42487,"timestamp":1734704940329},"postHourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.2488,"latestTime":"19:51 EST","volume":83305,"amount":21278.3585,"timestamp":1734742262626},"volumeRatio":3.2089399879511724},"requestUrl":"/m/hq/s/INAB/wiki","defaultTab":"wiki","newsList":[{"id":"2492414444","title":"In8Bio, Inc.盘中异动 急速拉升6.16%报0.255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414444?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:34","pubTimestamp":1734705273,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时34分，In8Bio, Inc.股票出现波动，股价大幅拉升6.16%。截至发稿，该股报0.255美元/股，成交量3.7886万股，换手率0.05%，振幅0.29%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223434984cfc34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223434984cfc34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2492177384","title":"In8Bio, Inc.盘中异动 急速跳水6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492177384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492177384?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:11","pubTimestamp":1734621111,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时11分，In8Bio, Inc.股票出现异动，股价快速下跌6.89%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231151a1fb69c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231151a1fb69c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2492215910","title":"In8Bio, Inc.盘中异动 临近收盘大幅跳水5.66%报0.272美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492215910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492215910?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:39","pubTimestamp":1734554375,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时39分，In8Bio, Inc.股票出现异动，股价大幅下挫5.66%。截至发稿，该股报0.272美元/股，成交量18.0433万股，换手率0.25%，振幅8.23%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.80%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904393595ea5adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904393595ea5adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2492047998","title":"In8Bio, Inc.盘中异动 大幅拉升5.97%报0.298美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492047998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492047998?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:28","pubTimestamp":1734456506,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时28分，In8Bio, Inc.股票出现异动，股价急速上涨5.97%。截至发稿，该股报0.298美元/股，成交量27.9066万股，换手率0.39%，振幅5.50%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801282695ea34f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801282695ea34f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2490181388","title":"In8Bio, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490181388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490181388?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:57","pubTimestamp":1733950659,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日04时57分，In8Bio, Inc.股票出现异动，股价急速拉升5.31%。截至发稿，该股报0.321美元/股，成交量24.1605万股，换手率0.33%，振幅3.38%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212045739984b64c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212045739984b64c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CADL","BK4139","INAB"],"gpt_icon":0},{"id":"2490017485","title":"In8Bio, Inc.盘中异动 急速下跌6.66%报0.314美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490017485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490017485?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:38","pubTimestamp":1733845124,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时38分，In8Bio, Inc.股票出现波动，股价大幅跳水6.66%。截至发稿，该股报0.314美元/股，成交量66.1474万股，换手率0.91%，振幅17.88%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210233844ab6d1582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210233844ab6d1582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2490775372","title":"In8Bio, Inc.盘中异动 股价大涨5.28%报0.325美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490775372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490775372?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:41","pubTimestamp":1733755304,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时41分，In8Bio, Inc.股票出现波动，股价快速拉升5.28%。截至发稿，该股报0.325美元/股，成交量7.0594万股，换手率0.10%，振幅7.22%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224144984ac544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224144984ac544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2488192064","title":"In8Bio, Inc.盘中异动 早盘股价大跌5.70%报0.301美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488192064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488192064?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:38","pubTimestamp":1733323089,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时38分，In8Bio, Inc.股票出现异动，股价急速跳水5.70%。截至发稿，该股报0.301美元/股，成交量6.5006万股，换手率0.09%，振幅7.83%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223810abf5cc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223810abf5cc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2488350946","title":"In8Bio, Inc.盘中异动 早盘大幅下挫5.84%报0.347美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488350946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488350946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:36","pubTimestamp":1733236582,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时36分，In8Bio, Inc.股票出现波动，股价急速下挫5.84%。截至发稿，该股报0.347美元/股，成交量25.8466万股，换手率0.36%，振幅4.08%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223622abf2faf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223622abf2faf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2488677016","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.02%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488677016?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:46","pubTimestamp":1733150787,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时46分，In8Bio, Inc.股票出现异动，股价急速拉升5.02%。截至发稿，该股报0.320美元/股，成交量8.3776万股，换手率0.12%，振幅3.22%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224627971b2ec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224627971b2ec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2486871872","title":"In8Bio, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486871872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486871872?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:06","pubTimestamp":1732723573,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时06分，In8Bio, Inc.股票出现异动，股价急速跳水5.00%。截至发稿，该股报0.295美元/股，成交量13.6641万股，换手率0.19%，振幅8.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128000613971a8ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128000613971a8ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2486388925","title":"In8Bio, Inc.盘中异动 股价大涨5.00%报0.319美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486388925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486388925?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:11","pubTimestamp":1732641101,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时11分，In8Bio, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报0.319美元/股，成交量12.3424万股，换手率0.17%，振幅6.58%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127011142a2578c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127011142a2578c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2486301051","title":"In8Bio, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486301051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486301051?lang=zh_cn&edition=full","pubTime":"2024-11-26 03:19","pubTimestamp":1732562376,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日03时19分，In8Bio, Inc.股票出现异动，股价快速下挫5.10%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126031936a25508e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126031936a25508e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2485441864","title":"In8Bio, Inc.盘中异动 股价大涨8.62%报0.349美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485441864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485441864?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:45","pubTimestamp":1732200322,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时45分，In8Bio, Inc.股票出现异动，股价大幅上涨8.62%。截至发稿，该股报0.349美元/股，成交量1.8285万股，换手率0.03%，振幅2.27%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224522abd4ecf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224522abd4ecf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2485014999","title":"In8Bio, Inc.2024财年第三财季实现净利润-7.09百万美元，同比增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485014999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485014999?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118437,"startTime":"0","endTime":"0","summary":"11月21日，In8Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-7.09百万美元，同比增加1.12%；其中营业收入为0.00美元，每股基本收益为-0.15美元。从资产负债表来看，In8Bio, Inc.总负债7.38百万美元，其中短期债务1.73百万美元，资产负债比为2.17，流动比率为1.85。机构评级：截至2024年11月21日，当前有5家机构对In8Bio, Inc.目标价做出预测，其中目标均价为4.10美元，其中最低目标价为1.50美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000044abd25bd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000044abd25bd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB"],"gpt_icon":0},{"id":"2484972491","title":"In8Bio, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484972491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484972491?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:29","pubTimestamp":1732044586,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时29分，In8Bio, Inc.股票出现波动，股价急速下挫5.16%。截至发稿，该股报0.315美元/股，成交量21.9672万股，换手率0.30%，振幅5.01%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032946971a781a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032946971a781a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2483301844","title":"In8Bio, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483301844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483301844?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:13","pubTimestamp":1731687204,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时13分，In8Bio, Inc.股票出现波动，股价大幅下跌5.24%。截至发稿，该股报0.318美元/股，成交量25.0355万股，换手率0.35%，振幅9.40%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.95%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116001324971a6e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116001324971a6e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2483135336","title":"In8Bio, Inc.盘中异动 下午盘股价大涨9.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483135336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483135336?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:31","pubTimestamp":1731612670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时31分，In8Bio, Inc.股票出现波动，股价大幅拉升9.73%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115033111abc1f22e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115033111abc1f22e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2483703667","title":"In8Bio, Inc.盘中异动 临近午盘急速拉升5.42%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483703667","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483703667?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:55","pubTimestamp":1731430514,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时55分，In8Bio, Inc.股票出现波动，股价快速上涨5.42%。截至发稿，该股报0.350美元/股，成交量9.9429万股，换手率0.14%，振幅4.58%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113005515a2310bbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113005515a2310bbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2482381357","title":"In8Bio, Inc.盘中异动 早盘股价大跌6.37%报0.322美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482381357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482381357?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:44","pubTimestamp":1731336277,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时44分，In8Bio, Inc.股票出现波动，股价大幅下挫6.37%。截至发稿，该股报0.322美元/股，成交量5.9313万股，换手率0.08%，振幅6.69%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224437971a5b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224437971a5b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":-0.1264},{"period":"1month","weight":-0.2261},{"period":"3month","weight":-0.2084},{"period":"6month","weight":-0.7201},{"period":"1year","weight":-0.8071},{"period":"ytd","weight":-0.8197}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于发现、开发和商业化用于实体和液体肿瘤的gamma-delta T细胞候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.098793},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.077829},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098136},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.097265},{"month":5,"riseRate":0.666667,"avgChangeRate":0.389911},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.253166},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.039223},{"month":8,"riseRate":0.25,"avgChangeRate":-0.195936},{"month":9,"riseRate":0.25,"avgChangeRate":-0.177333},{"month":10,"riseRate":0.5,"avgChangeRate":0.013341},{"month":11,"riseRate":0.25,"avgChangeRate":-0.10029},{"month":12,"riseRate":0.5,"avgChangeRate":0.138981}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}